← All companies

HCM

HUTCHMED (China) Limited

HCM Nasdaq Pharmaceutical Preparations EDGAR ↗

$11.55

+0.42 +3.77%

Key statistics

from XBRL data in SEC filings

Market cap

$10.1B

Revenue (TTM)

$549M

Net income (TTM)

$457M

EPS (TTM)

$0.52

P/E ratio

22.2

Dividend yield

—

Free cash flow

-$78.8M

Cash

$71.3M

Total assets

$1.75B

Gross margin

—

52-week range

$9.77 – $18.30

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 30, 2026 6-K Jul 2, 2026 6-K Jun 30, 2026 6-K Jun 29, 2026 6-K Jun 25, 2026 6-K Jun 12, 2026 6-K Jun 5, 2026 6-K May 22, 2026 6-K May 21, 2026 6-K May 12, 2026 6-K Apr 30, 2026 6-K Apr 29, 2026 6-K Apr 9, 2026 6-K FORM 6-K Apr 9, 2026 6-K Mar 23, 2026 6-K Mar 16, 2026 6-K Mar 11, 2026 6-K Mar 9, 2026 6-K Mar 6, 2026 6-K FORM 6-K Mar 5, 2026 20-F Mar 5, 2026 6-K Mar 4, 2026 6-K Feb 6, 2026 6-K Jan 14, 2026 6-K Jan 7, 2026 6-K Jan 5, 2026 6-K Dec 31, 2025 6-K Dec 30, 2025 6-K Dec 29, 2025 6-K Dec 17, 2025 6-K Dec 8, 2025 6-K Nov 28, 2025 6-K Nov 5, 2025 6-K Nov 3, 2025 6-K Oct 23, 2025 6-K Oct 21, 2025 6-K Oct 14, 2025 6-K Oct 2, 2025 6-K Sep 30, 2025 6-K Sep 12, 2025